The Drug That Could Break American Health Care
Rachel Sachs, associate professor of law
Seized House records show just how far Trump admin would go
Kathleen Clark, professor of law
What Does Europe Have Against Halal?
Food is becoming a target for anti-Islam politics in Europe, writes John Bowen, professor of sociocultural anthropology.
The Drug That Could Break American Health Care
Aduhelm, the first new Alzheimer’s drug in 18 years, may not work. But states and Medicare might pay billions of dollars for it anyway, argues the School of Law’s Rachel Sachs, an expert on drug pricing.
Biogen’s Costly, Unproven Drug Feared as Health Budget Buster
Rachel Sachs, associate professor of law
Alzheimer’s Drug Is Bonanza for Biogen, Most Likely at Taxpayer Expense
Erik Musiek, MD, associate professor of neurology
For many Black employees, working from home can provide relief from inequitable workplaces
Adia Harvey Wingfield, the Mary Tileston Hemenway Professor of Arts & Sciences
Awe makes us happier, healthier and humbler
Craig Anderson, postdoctoral research scholar in marketing
As virus cases drop, St. Louis hospital task force prepares to end weekly briefings, a pillar of the region’s pandemic response
Elvin Geng, MD, professor of medicine
Exxon board fight wasn’t about being woke. It was about poor performance
Todd Gormley, professor of finance
View More Stories